Vincerx Pharma Inc
VINC
Get informed when a big investor buys or sells
+ FollowMarket Cap$66.48K
Close$
$0.48
3700.8% upside
Current Fair Value
3700.8% upsideUndervalued by 3700.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $66,475.00 |
|---|---|
| Enterprise Value | $-2,101,525.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.75 |
| Beta | 1.46 |
| Outstanding Shares | 5,234,279 |
Return
| Return on Equity | -1096.08% |
|---|---|
| Return on Assets | -483.25% |
| Return on Invested Capital | -1322.31% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.08 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.08 |
| Debt to Equity | 1.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Vincerx Pharma Inc
28 employeesVincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment ...